Recombinant Factor VII a is associated with increased thrombotic complications in pediatric cardiac surgery patients

Anesthesia and Analgesia

Volumn 124, Issue 5, 2017, Pages 1431-1436

  Downey, Laura ^a   Brown, Morgan L ^a,b   Faraoni, David ^c   Zurakowski, David ^a,b   DiNardo, James A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7A; RECOMBINANT PROTEIN;

ADOLESCENT; ARTICLE; CARDIOPULMONARY BYPASS; CHILD; CLINICAL OUTCOME; CONTROLLED STUDY; CORONARY CARE UNIT; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; SURGICAL PATIENT; THROMBOSIS; ADVERSE EFFECTS; CHEMICALLY INDUCED; DEEP HYPOTHERMIC CIRCULATORY ARREST; HEART SURGERY; INTENSIVE CARE; NEWBORN; POSTOPERATIVE COMPLICATIONS; PRESCHOOL CHILD; RISK; STATISTICS AND NUMERICAL DATA; SURGEON;

ADOLESCENT; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; CIRCULATORY ARREST, DEEP HYPOTHERMIA INDUCED; CRITICAL CARE; FACTOR VIIA; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LENGTH OF STAY; MALE; POSTOPERATIVE COMPLICATIONS; PROPENSITY SCORE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; RISK; SURGEONS; THROMBOSIS;

EID: 85015653497     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000001947     Document Type: Article

References (28)

1. Guzzetta NA, Allen NN, Wilson EC, Foster GS, Ehrlich AC, Miller BE. Excessive postoperative bleeding and outcomes in neonates undergoing cardiopulmonary bypass. Anesth Analg. 2015;120:405-410.
2. Williams GD, Bratton SL, Ramamoorthy C. Factors associated with blood loss and blood product transfusions: A multivariate analysis in children after open-heart surgery. Anesth Analg. 1999;89:57-64.
3. Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Sys Rev. 2012;3:CD005011.
4. Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363:1791-1800.
5. Alfirevic A, Duncan A, You J, Lober C, Soltesz E. Recombinant factor VII is associated with worse survival in complex cardiac surgical patients. Ann Thorac Surg. 2014;98:618-624.
6. Sibylle A, Kozek-Langenecker, Arash A, et al. Management of severe perioperative bleeding guidelines from the European Society of Anaesthesiology. European guidelines. Eur J Anaesthesiol. 2013;30:270-382.
7. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management an updated report by the American Society of Anesthesiologists Task Force on perioperative blood management. Anesthesiology. 2015;122:241-275.
8. Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2011;25:987-994.
9. Agarwal HS, Bennett JE, Churchwell KB, et al. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. Ann Thorac Surg. 2007;84:161-168.
10. Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. J Intensive Care Med. 2004;19:270-273.
11. Schneider AG, Perez MH, Tozzi P, et al. Recombinant factor VIIa for intractable life-threatening bleeding in patients with circulatory assist devices. Intensive Care Med. 2010;36:1620-1621.
12. Niebler RA, Punzalan RC, Marchan M, Lankiewicz MW. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2010;11:98-102.
13. Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. Paediatr Anaesth. 2009;19:364-370.
14. McQuilten ZK, Barnes C, Zatta A, Phillips LE; Haemostasis Registry Steering Committee. Off-label use of recombinant factor VIIa in pediatric patients. Pediatrics. 2012;129:e1533-e1540.
15. Guzzetta NA, Russell IA, Williams GD. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. Anesth Analg. 2012;115:364-378.
16. Williams GD, Bratton SL, Riley EC, Ramamoorthy C. Association between age and blood loss in children undergoing open heart operations. Ann Thorac Surg. 1998;66:870-875.
17. Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE. Regression Methods in Biostatistics. New York: Springer; 2005:157-209.
18. Chan AK, Leaker M, Burrows FA, et al. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost. 1997;77:270-277.
19. Kern FH, Morana NJ, Sears JJ, Hickey PR. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg. 1992;54:541-546.
20. Brown AC, Hannan RH, Timmins LH, Fernandez JD, Barker TH, Guzzetta NA. Fibrin network changes in neonates after cardiopulmonary bypass. Anesthesiology. 2016;124:1021-1031.
21. Winger DG, Nason KS. Propensity-score analysis in thoracic surgery: when, why, and an introduction to how. J Thorac Cardiovasc Surg. 2016;151:1484-1487.
22. Austin PC. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: A systematic review and suggestions for improvement. J Thorac Cardiovasc Surg. 2007;134:1128-1135.
23. Faraoni D, Gardella KM, Odegard KC, Emani SM, DiNardo JA. Incidence and predictors for postoperative thrombotic complications in children with surgical and nonsurgical heart disease. Ann Thorac Surg. 2016;102:1360-1367.
24. Witmer CM, Huang YS, Lynch K, Raffini LJ, Shah SS. Off-label recombinant factor VIIa use and thrombosis in children: A multi-center cohort study. J Pediatr. 2011;158:820-825.e1.
25. Karsies TJ, Nicol KK, Galantowicz ME, Stephens JA, Kerlin BA. Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: A single institution experience. Ann Thorac Surg. 2010;89:570-576.
26. Kylasam S, Mos K, Fijtin S, Webster B, Chard R, Egan J. Recombinant activated factor VII following pediatric cardiac surgery. J Intensive Care Med. 2009;24:116-121.
27. Veldman A, Neuhaeuser C, Akintuerk H, et al. rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease. Paediatr Anaesth. 2007;17:1176-1181.
28. Manlhiot C, Menjak IB, Brandão LR, et al. Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery. Circulation. 2011;124:1511-1519.